Jonathan W. Goldman, Xuening Yang, Maximilian Hochmair, Lin Wu, Hye Ryun Kim, Luis G. Paz-Ares, Damian Tobias Rieke, Melissa Lynne Johnson, James Chih Hsin Yang, Masahiro Tsuboi, Benjamin Besse, Nivedita Sharma, Patricia H. Maeda, Patrick Peterson, Bente Frimodt-Moller, Yi Yang, Alexander E. Drilon, Yi-Long Wu. "Event-free survival with adjuvant selpercatinib in stage IB-IIIA
                    <i>RET</i>
                    fusion-positive NSCLC: Primary results of the phase 3 LIBRETTO-432 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba3